XNCR Stock Cash Flow Statements

Xencor Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Xencor Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31

cash flows from operating activities
net income	-30,825,000	-48,632,000		-46,297,000	-67,408,000	-68,709,000		-24,269,000	-21,954,000	-60,763,000	-12,042,000	-32,759,000	-33,974,000	23,594,000	73,061,000	-40,191,000	52,248,000	-2,487,000	-13,691,000	-12,550,000	-35,018,000	-8,074,000	-26,912,000	-10,225,000	-16,033,000	80,045,000	-18,199,000	3,151,000	-25,868,000	-29,493,000		-15,563,000	-6,884,000	-14,635,000		-8,077,000	47,165,000	-6,398,000	7,757,000	-10,037,000	-8,868,000	-6,444,000	-1,349,000	-6,278,000	-5,044,000	-3,751,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	2,653,000	2,693,000	2,994,000	3,054,000	3,024,000	3,035,000	3,228,000	3,140,000	2,885,000	2,245,000	2,159,000	2,238,000	2,224,000	2,178,000	2,107,000	1,993,000	1,753,000	1,638,000	1,532,000	1,446,000	1,443,000	1,373,000	1,225,000	1,070,000	1,007,000	996,000	883,000	816,000	822,000	730,000		556,000	454,000	410,000		371,000	346,000	282,000	345,000	274,000	254,000	240,000	261,000	135,000	166,000	320,000
accretion of discount on marketable debt securities	637,000	-2,126,000		-3,467,000	-4,436,000	-5,601,000
stock-based compensation	10,737,000	12,213,000	12,332,000	12,338,000	17,190,000	11,421,000	14,697,000	12,896,000	13,563,000	12,599,000	12,745,000	12,760,000	12,603,000	10,805,000	10,389,000	8,943,000	9,350,000	8,293,000	8,558,000	8,318,000	8,231,000	6,512,000	7,178,000	9,514,000	9,303,000	5,856,000	5,075,000	6,120,000	4,882,000	4,471,000		3,604,000	3,449,000	3,158,000		1,865,000	2,033,000	1,960,000	1,483,000	1,086,000	1,193,000	1,107,000	751,000	471,000	361,000	278,000
gain on sale of marketable securities
change in fair value of marketable equity securities
asset impairment charges	1,858,000	4,865,000
non-cash royalty revenue related to the sale of future royalties
non-cash interest expense on liabilities related to the sale of future royalties
changes in operating assets and liabilities:
accounts receivable	-8,769,000	23,405,000	-33,758,000	11,868,000											-45,839,000	-5,720,000	-2,300,000	-1,082,000	-1,909,000	-609,000	-2,100,000	14,749,000	-17,224,000	5,781,000	127,611,000	-127,489,000	-7,725,000	-1,180,000	-184,000	44,000		14,045,000	-7,938,000	1,678,000		147,266,000	-149,706,000	-604,000	364,000	45,000	-42,000	2,555,000	-2,947,000
prepaid expenses and other assets	-1,553,000	5,057,000	2,010,000	3,840,000	-7,250,000	1,559,000	3,511,000	465,000	-77,000	1,204,000	-397,000	-3,152,000	3,277,000	906,000		-5,290,000	-1,430,000	-3,438,000		-2,786,000	-914,000	71,000		3,775,000	-1,874,000	942,000		-67,000	-5,425,000	-1,043,000		756,000	-3,262,000	-1,465,000		-1,257,000	-348,000	-683,000
accounts payable	4,378,000	-568,000	-2,011,000	2,932,000	-173,000	2,097,000	-1,053,000	870,000	-1,245,000	5,254,000	-4,530,000	-1,129,000	3,842,000	-2,096,000	4,870,000	2,019,000	-551,000	-1,291,000	-4,155,000	2,596,000	200,000	124,000	1,884,000	-689,000	3,508,000	1,689,000	-2,186,000	1,067,000	-3,607,000	1,654,000		-778,000	3,105,000	395,000		-360,000	3,403,000	-2,109,000	1,293,000	2,030,000	688,000	699,000	-407,000
accrued expenses	5,785,000	-3,154,000	-6,190,000	5,850,000	6,066,000	-10,073,000	-908,000	6,032,000	3,300,000	-3,588,000	-561,000	2,941,000	3,736,000	-6,831,000	-2,665,000	4,780,000	4,815,000	-5,090,000	6,222,000	2,224,000	1,865,000	-1,703,000	1,163,000	1,606,000	521,000	-3,957,000	3,990,000	-251,000	1,312,000	-869,000		652,000	-2,518,000	-190,000		3,259,000	886,000	-1,243,000	-183,000	1,280,000	851,000	-523,000	487,000			72,000
operating lease	709,000	168,000
other assets and liabilities
net cash from operating activities	-36,369,000	-16,220,000	-55,575,000	-26,018,000	-65,337,000	-55,258,000	181,206,000	-27,281,000	-38,200,000	-30,614,000	-24,431,000	-1,168,000	44,269,000	5,815,000	61,790,000	-39,023,000	-9,654,000	-29,966,000	17,084,000	-3,866,000	-27,682,000	9,460,000	-19,577,000	-6,477,000	109,156,000	-18,728,000	-16,781,000	-10,311,000	-28,419,000	-24,245,000		-3,509,000	-12,788,000	-10,720,000		134,074,000	-9,369,000	-14,300,000	-3,845,000	39,520,000	-6,916,000	-2,093,000	-5,864,000
capex	-383,000	-1,444,000	-1,664,000	-1,275,000	-3,026,000	-132,000	-980,000	-2,832,000	-3,853,000	-10,783,000	-9,966,000	-14,085,000	-12,354,000	-2,089,000	-6,320,000	-2,745,000	-2,283,000	-1,951,000	-3,149,000	-4,695,000	-622,000	-2,073,000	-2,910,000	-2,576,000	-1,452,000	-415,000	-2,787,000	-1,009,000	-1,070,000	-2,346,000		-2,578,000	-762,000	-494,000		-740,000	-176,000	-317,000	-206,000	-609,000	-540,000	-575,000	-220,000
free cash flows	-36,752,000	-17,664,000	-57,239,000	-27,293,000	-68,363,000	-55,390,000	180,226,000	-30,113,000	-42,053,000	-41,397,000	-34,397,000	-15,253,000	31,915,000	3,726,000	55,470,000	-41,768,000	-11,937,000	-31,917,000	13,935,000	-8,561,000	-28,304,000	7,387,000	-22,487,000	-9,053,000	107,704,000	-19,143,000	-19,568,000	-11,320,000	-29,489,000	-26,591,000		-6,087,000	-13,550,000	-11,214,000		133,334,000	-9,545,000	-14,617,000	-4,051,000	38,911,000	-7,456,000	-2,668,000	-6,084,000
cash flows from investing activities
purchase of marketable debt securities												-110,910,000
purchase of property and equipment	-383,000	-1,444,000	-1,664,000	-1,275,000	-3,026,000	-132,000	-980,000	-2,832,000	-3,853,000	-10,783,000	-9,966,000	-14,085,000	-12,354,000	-2,089,000	-6,320,000	-2,745,000	-2,283,000	-1,951,000	-3,149,000	-4,695,000	-622,000	-2,073,000	-2,910,000	-2,576,000	-1,452,000	-415,000	-2,787,000	-1,009,000	-1,070,000	-2,346,000		-2,578,000	-762,000	-494,000		-740,000	-176,000	-317,000	-206,000	-609,000	-540,000	-575,000	-220,000
purchase of patents
proceeds from sales of marketable equity securities
proceeds from sales and maturities of marketable debt securities
net cash from investing activities	40,476,000	13,668,000	57,252,000	-163,458,000	66,016,000	32,318,000	-203,130,000	45,326,000	-1,405,000	48,144,000	24,548,000	3,125,000	-75,639,000	-71,759,000	7,860,000	-38,848,000	-53,309,000	38,048,000	78,779,000	-50,560,000	59,408,000	12,565,000	15,727,000	22,060,000	-102,430,000	13,673,000	6,866,000	5,862,000	-190,169,000	12,674,000		4,933,000	9,351,000	8,727,000		-127,665,000	8,623,000	9,660,000	-41,690,000	6,933,000	-101,291,000	-49,058,000	-587,000
cash flows from financing activities
proceeds from the exercises of stock options	0	2,974,000
proceeds from issuance of common stock under the employee stock purchase plan				0				0				0				0				0				0				0				1,000				0				0				-7,000
cash paid to acquire noncontrolling interest	0	-1,725,000
net cash from financing activities	662,000	1,249,000	10,169,000	187,740,000	-943,000	186,000	22,983,000	356,000	1,921,000	922,000	1,171,000	1,287,000	2,513,000	731,000	32,630,000	3,229,000	1,840,000	5,339,000	9,587,000	2,986,000	4,000,000	1,471,000	2,973,000	3,049,000	3,973,000	667,000	1,165,000	4,153,000	2,308,000	246,615,000		990,000	1,096,000	1,026,000		501,000	473,000	200,000	387,000	114,000	330,000	115,550,000	177,000	-2,000	131,000	2,000
net increase in cash, cash equivalents, and restricted cash						-22,754,000
cash, cash equivalents, and restricted cash, beginning of period	0	41,262,000		0	0	54,170,000
cash, cash equivalents, and restricted cash, end of period	4,769,000	39,959,000		-1,736,000	-264,000	31,416,000
supplemental disclosure of cash flow information
interest paid	1,000	1,000
income taxes paid
gain on sale of marketable debt securities				0	0	-3,000
change in fair value of equity securities		-941,000	30,974,000	-9,254,000	12,027,000	-2,325,000	-13,238,000	11,023,000	-288,000	2,898,000	-28,110,000	-5,298,000	6,545,000	3,429,000	18,218,000	-1,505,000
non-cash royalty revenue		-18,232,000
non-cash interest expense on liability related to the sale of future royalties		8,664,000
loss on disposal of assets			1,571,000	0	0	6,000	-1,000	1,000	0	1,379,000	13,000			117,000	445,000				0	-1,000			0	3,000
others		368,000
purchase of marketable securities		-103,873,000	-54,210,000	-281,714,000	-122,598,000	-136,532,000	-338,425,000	-167,765,000	-181,487,000	-95,228,000				-88,764,000	-121,771,000	-156,367,000	-147,320,000	-84,139,000	-166,348,000	-174,991,000	-159,842,000	-142,477,000	-144,681,000	-107,675,000	-194,643,000	-49,856,000	-46,714,000	-45,317,000	-254,112,000	-31,697,000		-15,763,000	-26,452,000	-6,988,000		-195,024,000	9,217,000	-16,340,000	-47,309,000	-20,161,000	-100,415,000	-47,913,000
proceeds from maturities of marketable securities		118,985,000		117,975,000	188,024,000	159,942,000															220,801,000	157,653,000		133,079,000	94,778,000	64,995,000
proceeds from sale of marketable securities				0	0	9,969,000
net decrease in cash, cash equivalents, and restricted cash		-1,303,000		-1,736,000
consolidated net income
(accretion of discount) amortization of premium on marketable debt securities								-3,866,000
abandonment of capitalized intangible assets			150,000	1,395,000	369,000	415,000	470,000	203,000	273,000	321,000	179,000	284,000	736,000	311,000	207,000	417,000	117,000	193,000	132,000	236,000	139,000	28,000	106,000	25,000	32,000	58,000	121,000	68,000	45,000	5,000		48,000	216,000	9,000		62,000	36,000	9,000	16,000	226,000	17,000	37,000	13,000	365,000	121,000	10,000
gain on sale of available-for-sale marketable debt securities
equity received in connection with license agreement																			-22,071,000	0	0	-4,589,000
impairment on equity securities			0	0	-220,000	20,650,000						0
noncash royalty revenue related to sale of future royalties
noncash interest expense
interest receivable from marketable debt securities			-310,000	-1,426,000	-395,000	-1,310,000	-1,141,000	-307,000	172,000	248,000	-138,000	56,000	-197,000	-251,000
income taxes			1,298,000	0																804,000				-400,000	704,000	900,000		1,000	0	-157,000		-455,000	280,000	110,000		-1,381,000
lease liabilities and rou assets			167,000	948,000	213,000	213,000	2,513,000	155,000	251,000	331,000	1,805,000	13,260,000	6,175,000	1,736,000								-54,000	-49,000	-45,000	194,000	1,254,000
deferred revenue							-9,222,000	1,357,000	-22,239,000	-216,000	-4,866,000	-113,000	-189,000	-1,806,000	24,344,000	-6,250,000	-58,621,000	-14,794,000	48,775,000	-845,000	-1,491,000	-955,000	-1,061,000	-586,000	-14,362,000	23,061,000	0					-7,091,000	-740,000	-340,000		-7,483,000	84,493,000	-5,952,000	-14,755,000	44,406,000	-322,000	-91,000	-2,702,000
proceeds from maturities of marketable debt securities available-for-sale
proceeds from sale of marketable debt securities available-for-sale
proceeds from sale of equity securities
proceeds from sale of property and equipment															15,000	0																							0	0	8,000	1,000	1,000	0
purchase of intangible assets						-929,000	-726,000	-587,000	-1,083,000	-407,000	-933,000	-780,000	-2,291,000	-906,000	-334,000	-1,024,000	-1,252,000	-72,000	-1,086,000	-676,000	-929,000	-538,000	-753,000	-768,000	-1,113,000	-1,051,000	-633,000	-420,000	-493,000	-389,000		-428,000	-390,000	-702,000		-446,000	-418,000	-343,000	-525,000	-305,000	-344,000	-571,000	-368,000
conversion of convertible note
proceeds from issuance of common stock and pre-funded warrants			0
common stock and pre-funded warrants issuance costs			0
proceeds from issuance of common stock upon exercise of stock awards			3,701,000	685,000	140,000	1,787,000	1,455,000	356,000	679,000	922,000	276,000	1,287,000	1,316,000	731,000	2,810,000	3,229,000	903,000	5,339,000	8,885,000	2,986,000	3,275,000	1,471,000	2,314,000	3,049,000	3,239,000	667,000	549,000	4,153,000	1,805,000	1,110,000		989,000	654,000	1,026,000		501,000	247,000	200,000	11,000	114,000	249,000	180,000	1,000			4,000
proceeds from issuance of common stock from employee stock purchase plan
proceeds from sale of future royalties
proceeds from non-controlling interest
cash, cash equivalents, and restricted cash, beginning of year
cash, cash equivalents, and restricted cash, end of year
equity received in connection with license agreements								0
non-cash interest expense				782,000	833,000	1,067,000
deferred income				-8,581,000	-6,902,000	-9,410,000
sale of equity securities				2,403,000
purchase of patents, licenses, and other intangible assets				-847,000
reduction of liability for sale of future royalties				-2,124,000
accounts receivable and contract asset						1,710,000		-34,981,000	-157,000	9,135,000		9,408,000	38,920,000	-26,820,000
repayment of liability for sale of future royalties						-1,601,000
cash paid during the period for:
interest						11,000	1,000	7,000	7,000	7,000	0	4,000	5,000	4,000	1,000	4,000	5,000	4,000	0	4,000	5,000	6,000	0	4,000	3,000	4,000	7,000	3,000	3,000	3,000		3,000	2,000	3,000											3,000	2,000
supplemental disclosures of non-cash activities
unrealized gain on marketable securities						-1,445,000		1,151,000	1,766,000	3,327,000				-5,611,000			-113,000	23,000		-916,000
rou assets obtained						7,166,000
reconciliation of cash, cash equivalents, and restricted cash reported in the balance sheets
cash and cash equivalents						31,034,000
restricted cash						382,000
total cash, cash equivalents, and restricted cash shown in the statement of cash flows						31,416,000
amortization of premium (accretion of discount) on marketable securities															528,000	921,000	846,000	865,000
equity received in connection with sale of financial assets															0	0
equity securities impairment
accounts receivable and contract assets
income tax
proceeds from sale and maturities of marketable debt securities available-for-sale
conversion (purchase) of convertible note
exercise of stock options
proceeds from issuance of common stock																											0	0	0	260,245,000									0	0	0	122,906,000
supplemental disclosures of cash flow information
cash paid for:
taxes
supplemental schedule of noncash activities
net unrealized gain on marketable securities available-for-sale																																						619,000
addition of right-of-use asset
proceeds from maturities and sale of marketable securities								216,510,000	185,018,000	154,562,000				20,000,000		122,130,000	97,542,000	124,210,000
supplemental disclosures of non-cash investing activities
net decrease in cash and cash equivalents												3,244,000																					-2,341,000	-967,000
cash and cash equivalents, beginning of period									0	53,942,000		0	0	143,480,000		0	0	163,544,000		0	0	50,312,000		0	0	26,246,000		0	0	16,528,000		0	0	14,528,000		0	0	12,590,000		0	0	54,649,000
cash and cash equivalents, end of period									-37,684,000	72,394,000		3,244,000	-28,857,000	78,267,000		-74,642,000	-61,123,000	176,965,000		-51,440,000	35,726,000	73,808,000		18,632,000	10,699,000	21,858,000		-296,000	-216,280,000	251,572,000		2,414,000	-2,341,000	13,561,000		6,910,000	-273,000	8,150,000		46,567,000	-107,877,000	119,048,000
amortization of premium on marketable securities										-1,661,000		-59,000	425,000	543,000													-462,000	-338,000	-74,000	480,000		792,000	697,000	659,000		522,000	450,000	426,000	454,000	402,000	177,000	63,000
net increase in cash and cash equivalents										18,452,000				-65,213,000	102,280,000	-74,642,000	-61,123,000	13,421,000	105,450,000	-51,440,000	35,726,000	23,496,000	-877,000	18,632,000	10,699,000	-4,388,000	-8,750,000	-296,000	-216,280,000	235,044,000	2,894,000				-259,000			-4,440,000	-45,148,000	46,567,000	-107,877,000	64,399,000
gain on sale of marketable securities available-for-sale
cash redemption of equity received in connection with license agreement
contract asset and deposits															0	121,000	12,000,000	-62,000	-12,454,000
proceeds from sale and maturities of marketable securities available-for-sale																																						26,660,000
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
purchase of equity securities
proceeds from maturities of marketable debt securities

unrealized loss on marketable debt securities												-931,000
gain on disposal of assets
proceeds from maturities and sale of marketable debt securities
prepaid expenses and other current assets																																									-392,000	-142,000
income tax receivable
deferred rent																							0	0	0	-1,513,000	-68,000	260,000	-36,000	242,000		371,000	18,000	-30,000		-9,000	-27,000	-26,000	-23,000	-22,000	64,000	553,000
purchase of convertible note
supplemental schedule of noncash investing activities
gain on sale of marketable securities available for sale																				0
interest receivable																-314,000	185,000	311,000	55,000	221,000	699,000	215,000	-384,000	151,000	-185,000	31,000	89,000	-29,000	-286,000	-309,000		-444,000	335,000	-479,000		-701,000	119,000	41,000	-239,000	11,000	-524,000	-146,000
lease liabilities and right of use (rou) assets																469,000	-41,000	-42,000		-58,000
unrealized loss on marketable securities
(gain) loss on disposal of assets
change in fair value of equity security																		-12,980,000	689,000	-2,772,000	-358,000	2,336,000
income tax payable
proceeds from repayment of loan receivable
common stock issuance costs																											0	0	-1,000	-14,740,000									0	0	-166,000	-7,536,000
accretion of discount on marketable securities																				-143,000	-265,000	-573,000
unrealized gain on marketable securities, net of tax																						-105,000		-193,000	1,284,000	1,316,000		-730,000	593,000	-393,000		143,000	-44,000	245,000
loss on sale of marketable securities available-for-sale
other assets																																														50,000
proceeds from repayment of (investment in) loan receivable
amortization of premium and accretion of discount on marketable securities																								-1,457,000	-1,275,000	-601,000
contract asset
repayment of loan
repayment (issuance) of loan
proceeds from sale and maturities of marketable securities																													65,506,000	47,020,000		23,700,000	36,955,000	16,911,000		68,545,000
loan receivable																													0	86,000
net cash provided by:
operating activities
investing activities
financing activities
net unrealized gain on marketable securities, net of tax
gain on sale and maturities of marketable securities available-for-sale
loss on exchange of notes for preferred stock
accrued interest on convertible promissory notes
proceeds from sale of series a-1 preferred stock
preferred stock issuance cost
payments on capital lease obligations
net unrealized loss on marketable securities available-for-sale																																							510,000
supplemental schedule of noncash financing activities
settlement of notes payable for preferred stock
proceeds from sale of marketable securities available-for-sale
net unrealized loss on marketable securities available for sale																																									55,000	35,000
supplemental disclosures of non-cash investing and financing activities
gain from non-monetary exchange
proceeds from sale of series a-1preferred stock
proceeds from sale of common stock
payments of initial public offering costs
capitalization of licensing rights acquired in non-monetary exchange
equipment acquired under capital lease
proceeds from the sale of series a-1 preferred
preferred stock issuance costs
net increase in cash
cash, beginning of period																																												0	0	77,975,000
cash, end of period																																												-5,295,000	-6,318,000	72,536,000
money market funds

We provide you with 20 years of cash flow statements for Xencor stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Xencor stock. Explore the full financial landscape of Xencor stock with our expertly curated income statements.

The information provided in this report about Xencor stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.